Biomarkers for prostate cancer detection and risk stratification
Although prostate cancer (PCa) is the most commonly diagnosed cancer in men, most
patients do not die from the disease. Prostate specific antigen (PSA), the most widely used …
patients do not die from the disease. Prostate specific antigen (PSA), the most widely used …
Beyond PSA: the next generation of prostate cancer biomarkers
JR Prensner, MA Rubin, JT Wei… - Science translational …, 2012 - science.org
Since the introduction of serum prostate-specific antigen (PSA) screening 25 years ago,
prostate cancer diagnosis and management have been guided by this biomarker. Yet, PSA …
prostate cancer diagnosis and management have been guided by this biomarker. Yet, PSA …
Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.
The introduction and widespread adoption of PSA has revolutionized the way prostate
cancer is diagnosed and treated. However, the use of PSA has also led to over-diagnosis …
cancer is diagnosed and treated. However, the use of PSA has also led to over-diagnosis …
Serum markers for prostate cancer: a rational approach to the literature
T Steuber, MF O'Brien, H Lilja - European urology, 2008 - Elsevier
INTRODUCTION: Due to its universal applicability for early detection and prediction of
cancer stage and disease recurrence, widespread implementation of serum-based prostate …
cancer stage and disease recurrence, widespread implementation of serum-based prostate …
PSA and beyond: alternative prostate cancer biomarkers
S Saini - Cellular Oncology, 2016 - Springer
Background The use of biomarkers for prostate cancer screening, diagnosis and prognosis
has the potential to improve the clinical management of the patients. Owing to inherent …
has the potential to improve the clinical management of the patients. Owing to inherent …
[HTML][HTML] Recent progress and perspectives on prostate cancer biomarkers
S Hatakeyama, T Yoneyama, Y Tobisawa… - International journal of …, 2017 - Springer
The application of prostate-specific antigen (PSA) in prostate cancer (PC) screening,
diagnosis, and prognosis has improved the clinical management of PC patients. However …
diagnosis, and prognosis has improved the clinical management of PC patients. However …
[PDF][PDF] An overview of biomarkers in the diagnosis and management of prostate cancer
A Uhr, L Glick, LG Gomella - Can J Urol, 2020 - canjurol.com
Introduction: Prostate cancer is a common malignancy with highly variable clinical
presentation and outcomes. Diagnosis and management remain a challenge and at times …
presentation and outcomes. Diagnosis and management remain a challenge and at times …
Novel biomarkers for the detection of prostate cancer
NA Jakobsen, FC Hamdy… - Journal of Clinical …, 2016 - journals.sagepub.com
Prostate-specific antigen (PSA) is widely used as a biomarker in the detection of prostate
cancer and for decision making regarding treatment options, response to therapy, and …
cancer and for decision making regarding treatment options, response to therapy, and …
Circulating biomarkers for prostate cancer
T Steuber, P Helo, H Lilja - World journal of urology, 2007 - Springer
Due to its significant applicability for early detection, risk prediction and follow-up evaluation,
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
prostate specific antigen (PSA) has revolutionized our ability to treat prostate cancer …
[HTML][HTML] Commercialized blood-, urinary-and tissue-based biomarker tests for prostate cancer diagnosis and prognosis
WCH Visser, H de Jong, WJG Melchers, PFA Mulders… - Cancers, 2020 - mdpi.com
Simple Summary In prostate cancer diagnosis and prognosis, clinicians often must take
decisions on which prostate cancer-suspected patients should undergo biopsy and which …
decisions on which prostate cancer-suspected patients should undergo biopsy and which …